ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alain Bernard
Jean-Pierre Favre
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, A.
Right arrow Articles by Favre, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, A.
Right arrow Articles by Favre, J.-P.

Ann Thorac Surg 2000;70:1161-1167
© 2000 The Society of Thoracic Surgeons


Original articles: general thoracic

Identification of prognostic factors determining risk groups for lung resection

Alain Bernard, MDa, Loic Ferrand, MDa, Olivier Hagry, MDa, Laurent Benoit, MDa, Nicolas Cheynel, MDa, Jean-Pierre Favre, MDa

a Department of Thoracic Surgery, France

Address reprint requests to Dr Bernard, Hôpital Universitaire, 2 bd Marechal de Lattre de Tassigny, BP 1542, 21034 Dijon CEDEX, France
e-mail: alain.bernard{at}chu-dijon.fr


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Background. Pulmonary resection belongs to a group of surgical procedures with significant morbidity and mortality. The aims of this study were to classify postoperative complications and to identify prognostic factors determining risk group.

Methods. In a prospective study 500 patients undergoing lung resection (wedge resection, n = 141; lobectomies, n = 245; bilobectomies, n = 12; and pneumonectomies, n = 102) were included. In 178 patients (36%) pulmonary resections were extended to structures or thoracic organs. Sleeve resection of the bronchus to preserve lung parenchyma was performed in 22 patients.

Results. Classification of postoperative complications fell into four categories: patients without postoperative complications; patients with moderate complications (n = 137); patients with severe complications (n = 38); and death (n = 33). Factors adversely affecting postoperative complications by multivariate analysis included pulmonary pathology, bronchoplastic technique, forced expiratory volume in 1 second (FEV1), extended resection, type of lung resection, comorbidity indices, and preoperative chemotherapy. Four risk groups were determined. Risk group I (n = 60) with the best prognosis included patients with FEV1 greater than or equal to 80% undergoing wedge resection for a benign lesion or metastasis. Risk group II (n = 161) included patients with FEV1 greater than or equal to 80% undergoing major pulmonary resection for a benign lesion or metastasis or lung cancer, or patients with FEV1 less than 80% undergoing wedge resection for benign lesion or metastasis. Risk group III (n = 233) with a fair prognosis included patients with comorbidity indices less than 4 and FEV1 greater than or equal to 80% undergoing extended pulmonary resection for a benign lesion or metastasis or lung cancer, or patients with FEV1 less than 80% and emphysema. Risk group IV (n = 46) with the worst prognosis included patients with FEV1 less than 80% undergoing an extended lung resection or bronchoplastic procedures for a benign lesion or metastasis or lung cancer, or patients with comorbidity indices greater than or equal to 4 undergoing extended lung resection for lung cancer.

Conclusions. In a prospective study, based on these prognostic factors, a practical, easy-to-use risk group system of lung resection is proposed as a tool to aid the decision to perform lung resection.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Pulmonary resection belongs to the group of surgical procedures with significant morbidity and mortality. Significant ventilatory impairment is caused not only by parenchyma amputation but also by deterioration of respiratory mechanics. Some studies reported a decrease of postoperative mortality rate for resectional operations for lung cancer [1]. New techniques of perioperative and postoperative care have led to a further decline in postoperative complication rates [1]. Over the past years, the mean age of patients has increased; more and more patients 75 years old or more are being seen by thoracic surgeons.

Often in patients with pulmonary pathology, the rate of coexistent medical conditions is high. Pulmonary resection is associated with comorbid disease, which explains a high rate of postoperative complications [2]. For risk assessment of pulmonary resection, analysis must be adjusted for comorbidity disease [3].

Lung cancer represents the major reason for which patients undergo pulmonary resectional surgery. Often, extended resection is necessary because of the size or localization of the pulmonary tumor so as to perform a curative resection.

To answer these questions about postoperative complications after pulmonary resection, we performed a prospective study. The aims of this study were to classify postoperative complications and to identify prognostic factors determining risk group.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Selection of patients
From January 1996 to December 1998, 500 patients who underwent single or multiple wedge lobectomies or bilobectomies or pneumonectomies were included in this prospective study. Subjects who underwent exploratory or staging thoracotomy procedures or thoracoscopy without resection of lung parenchyma were excluded from the study. The mean age of patients was 59 ± 12 years (range 16 to 84); there were 410 males and 90 females.

Pulmonary resection was indicated for bronchectasis in 7 cases (1%), invasive aspergillosis in 7 cases (1%), emphysema in 19 cases (4%), infectious disease in 31 cases (6%), metastasis in 41 cases (8%), benign lesion in 54 cases (11%), and lung cancer in 341 cases (68%). In 10 patients with lung cancer, wedge resection was a diagnostic procedure. Of the 500 resections for pulmonary pathology, there were 141 wedge resections (28%), 245 lobectomies (49%), 12 bilobectomies (2%), and 102 pneumonectomies (20%). Video-assisted thoracic surgery was used to perform 78 wedge resections and 2 lobectomies. Through posterolateral thoracotomy, 56 wedge resections, 241 lobectomies, 12 bilobectomies, and 97 pneumonectomies were performed. Through median sternotomy, 7 wedge resections, 2 lobectomies, and 5 pneumonectomies were performed. In 178 patients (36%) pulmonary resections were extended to structures or thoracic organs: pericardium (n = 81), left atrium (n = 20), superior vena cava (n = 7), aortic adventice (n = 17), trachea or carina (n = 9), diaphragm (n = 6), parietal pleura (n = 72), and chest wall (n = 29). Sleeve resection of the bronchus to preserve lung parenchyma was performed in 22 patients. A sleeve lobectomy of the right upper lobe was performed in 7 patients, of the right lower lobe in 7 patients, of the right middle and lower lobe in 2 patients, of the upper lobe in 3 patients, and of the lower lobe in 3 patients.

Data collection
Preoperative assessment included the documentation of historic information (comorbid diseases, obesity, weight loss, and tobacco use) as well as functional status (Karnofsky index).

Associated comorbidity factors were defined as coronary artery disease (angor or myocardial infarction), congestive heart failure, peripheral vascular disease, cerebrovascular disease, chronic obstructive pulmonary disease (asthma or emphysema or bronchitis), chronic renal failure, severe liver disease (cirrhosis), and malignancy. Comorbidity indices were calculated using Romano’s method [2] for each patient by summarizing weighted comorbidity profile components. Coronary artery disease was assigned a weight of 1; congestive heart failure a weight of 3; peripheral vascular disease a weight of 2; cerebrovascular disease a weight of 1; chronic renal failure a weight of 2; diabetes a weight of 2; severe liver disease a weight of 3; chronic obstructive pulmonary disease a weight of 2; and malignancy a weight of 2. Preoperative chemotherapy or corticosteroids were included in risk factors. Preoperative pulmonary evaluation included arterial blood gas analysis (PaO2 and PaCO2) and spirometry, forced expiratory volume in 1 second (FEV1) expressed to percents with regard to theoretical FEV1, and forced vital capacity (FVC) expressed to percents with regard to theoretical FVC.

Postoperative outcomes
All patients were followed up prospectively after surgery and complications occurring during the same hospitalization as the index procedure were recorded. Complications were defined to include respirations complications: pneumonia (fever > 38°C, purulent sputum, abnormal findings on chest radiograph), atelectasis, prolonged air leak (duration of chest tube drainage > 7 days), postlobectomy space, bronchopleural fistula, empyema, adult respiratory distress syndrome, respiratory failure, mechanical ventilation for longer than 2 days, bleeding, and wound infection), cardiac complications (arrhythmias, myocardial infaction, congestive heart failure, pulmonary embolism), and acute renal failure. Operative deaths included both patients who died within 30 days after operation and those who died later but during the same hospitalization.

Statistical analysis
Multiple correspondence analysis was used to classify postoperative complications according to their gravity. Multiple correspondence analysis allowed regrouping variables that had a strong association [3]. Prognostic factors for postoperative complications were identified through univariate analysis using {chi}2 tests. After univariate analysis, variables that had a probability lower than 0.1 were included in multivariate logistic regression for multinomial data to identify prognostic factors [4]. Adjusted odds ratios with 95% confidence intervals were calculated by exponentiating the logistic coefficients estimates. Next, regression tree analyses were performed according to the method of Breiman and associates [5] by considering the prognostic factors. These regression tree analyses using hierarchical classification were performed to determine different risk groups [5]. The algorithm used the {chi}2 values as criterion for amalgamating subgroups [5].


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Classification of postoperative complications
In the graphical display of multiple correspondence analysis (Fig 1), some variables that had a strong association allowed determination of four categories of patients. The first category consisted of patients without postoperative complications (Fig 1). The second category included a group of variables: pneumonia, atelectasis, prolonged air leak, postlobectomy space, bleeding, arrhythmias, and wound infection (Fig 1); this category corresponded to moderate complications that could be cared for in a thoracic surgery care unit. The third category included a variable with a strong association such as adult respiratory distress syndrome, respiratory failure, mechanical ventilation for longer than 2 days, myocardial infaction, congestive heart failure, acute renal failure, bronchopleural fistula, or empyema (Fig 1); this category corresponded to severe complications requiring coverage in an intensive care unit. Finally, the fourth category consisted of patients who died during hospitalization (Fig 1). Among 208 patients (42%) developing postoperative complications, 137 patients (27%) had moderate complications, 38 patients (8%) had severe complications, and 33 patients (7%) died (Table 1).



View larger version (14K):
[in this window]
[in a new window]
 
Fig 1. Graphic display of multiple correspondence analysis: Axis 1 corresponds to the alive and dead patients. Axis 2 corresponds to various not-mortal complications; the further the type of complication went from 0, the more severe it was. This display shows that a strong association between some variables determined four categories: (1) patients without complications, (2) patients with moderate complications, (3) patients with severe complications, and (4) death. (ARDS = adult respiratory distress syndrome.)

 

View this table:
[in this window]
[in a new window]
 
Table 1. Description and Classification of Complications Occurring in 500 Patients After Lung Resection

 
Determining prognostic factors
In univariate analysis, age, sex, Karnofsky index, weight loss, tobacco use, comorbidity indices, preoperative chemotherapy, corticosteroids, FEV1, FVC, and pulmonary pathology were associated significantly with postoperative complications (Table 2). Obesity and arterial blood gas were unrelated to postoperative complications. Table 2 shows that in-hospital severe complications and postoperative mortality varied, respectively, from 6% and 3% after wedge resection, 7% and 9% after lobectomy or bilobectomy, and 10% and 7% after pneumonectomy. Patients undergoing extended resection had a significantly higher rate of severe complications (9.5%) and of postoperative mortality (12%; Table 2). Patients undergoing bronchoplastic technique had a significantly higher rate of postoperative mortality (36%; Table 2). Patients undergoing mediastinal lymphadenectomy for lung cancer had a significantly higher rate of moderate complications (35%; Table 2). Pneumonia rates were 29% (n = 71) after lobectomy, 42% (n = 5) after bilobectomy, and 20% (n = 20) after pneumonectomy. Pneumonia rates were 30% (n = 54) after extended resection and 54.5% (n = 12) after bronchoplastic techniques. Bronchopleural fistula rates were 3% (n = 8) after lobectomy, 17% (n = 2) after bilobectomy, and 9% (n = 9) after pneumonectomy. Bronchopleural fistula rates were 23% (n = 5) after bronchoplastic techniques.


View this table:
[in this window]
[in a new window]
 
Table 2. Prognostic Factors Associated Significantly With Postoperative Complications in Univariate Analysis

 
In multivariate analysis, pulmonary pathology (p = 0008), bronchoplastic techniques (p = 0.0003), FEV1 (p = 0.0002), extended resection (p = 0.0001), type of lung resection (p = 0.003), comorbidity indices (p = 0.02), and preoperative chemotherapy remained independently associated postoperative complications (p = 0.02; Table 3). Benign lesion and metastases were regrouped because they had equivalent odds ratio and were close to 1 in multivariate analysis (Table 3). Wedge resection and pneumonectomy had an odds ratio little different from 1 (Table 3).


View this table:
[in this window]
[in a new window]
 
Table 3. Variables Remaining by Logistic Model and Independently Associated With Postoperative Complications

 
Determining risk groups
Using the prognostic factors outlined in Table 3, a regression tree analysis was performed. Preoperative chemotherapy was not included in the regression tree analysis because reasons for decreasing risk for postperative complications by this variable were not obvious. After pruning, a tree with 11 terminal nodes was chosen. Terminal nodes with similar prognostic profiles were merged together based on the {chi}2 values of hierarchical classification. Eleven terminal nodes were adjusted into 4 risk groups, ranging in size from 46 to 233 patients (Table 4). Risk group I (Table 4) included 60 patients who underwent wedge resection for a benign lesion or metastasis and had FEV greater than 80%. This risk group had the best prognosis (Table 5). Risk group II (Table 4) included 161 patients with FEV1 greater than or equal to 80% who underwent major pulmonary resection for a benign lesion or metastasis or lung cancer. This risk group also included patients with FEV1 less than 80% who underwent wedge resection for a benign lesion or metastasis. Risk group III (Table 4) included 233 patients with comorbidity indices less than 4 and FEV1 greater than or equal to 80% who underwent extended pulmonary resection for lung cancer. This risk group also included patients with FEV1 less than 80%, who had pulmonary resection for lung cancer or emphysema. This risk group had a fair prognosis (Table 5). Risk group IV (Table 4) included 46 patients with FEV1 less than 80% who had an extended lung resection or bronchoplastic procedures for a benign lesion or metastasis or lung cancer. This risk group IV also included patients with comorbidity indices greater than or equal to 4 and FEV1 greater than or equal to 80% who had extended lung resection for lung cancer. This group had the worst prognosis (Table 5).


View this table:
[in this window]
[in a new window]
 
Table 4. Definitions of Prognostic Factor Risk Groups of Patients Who Had Lung Resection

 

View this table:
[in this window]
[in a new window]
 
Table 5. Estimated Postoperative Complication Rates for All Risk Groups

 

    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
This study of 500 patients who underwent pulmonary resection demonstrated high postoperative complications. Most authors report morbidity rate ranging from 15% to 47% [69]. This discrepancy between different series could be explained by the methodology used. Most retrospective studies were biased because data collection was less complete than in prospective studies. Other authors [10] are only interested in some complications such as respiratory failure, pneumonia, atelectasis, and arrhythymias. Among all postoperative complications combined, pneumonia is reported to occur in approximately 22% of patients and is associated with death in 19% of patients [610]. Often the cardiac complications are associated with other severe complications such as respiratory failure or bronchopleural fistula [610].

At present, no study has used this classification for postoperative complications. Our classification also agrees with a treatment of postoperative complications; indeed, moderate complications can be treated in a general thoracic unit; on the other hand, severe complications would be cared for in an intensive care unit. Our classification allows a more realistic description of postoperative complications, and it could be used to make prospective studies more homogeneous.

A postoperative mortality rate of 1% to 12% has been reported in previous studies [615]. This great variability could be explained by pulmonary disease or by the type of procedure [615]. Studies that reported pulmonary resection for lung cancer had higher mortality rates than other studies [1115]. In the majority of studies [1118], the crude mortality rates after major lung resections are still significant: 3% to 12% for pneumonectomy, 3% to 5% for lobectomy, and 1% to 3% for wedge resection, respectively. Extended lobectomy involving the chest wall, pleura, pericardium, or diaphragm are associated with increased mortality [615].

The frequency of bronchopleural fistula after pneumonectomy has ranged between 4% and 9% [1618]. Bronchopleural fistula remains a severe complication because the mortality rates range from 29% to 79% in our data and in the literature review of Kopec and associates [17].

Bronchoplastic techniques are associated with increased morbidity, particularly pneumonia and bronchopleural fistula in our data. Other authors [19, 20] reported mortality rates ranging from 5% to 10%. In patients with poor pulmonary reserve, needing preservation of as much lung tissue as possible, bronchoplastic techniques are indicated. Reinforcement of a closed bronchial anastomosis with a muscle flap could reduce dehiscence.

The literature has identified numerous risk factors for poor outcomes after pulmonary resection: age, type and extent of surgery, abnormal spirometry, male sex, and comorbidity [11, 12, 15, 21, 22]. However, the sample sizes in most of these studies have been too small to apply multivariate statistical methods. Among studies reporting that being 75 years of age or older increases a postoperative mortality [11, 12, 15], two studies [12, 15]did not adjust for comorbidity and spirometry. Lung resection can be performed routinely in patients 75 years of age and older without comorbid disease.

Most of the studies identified FEV1 lower than 80% as a risk factor [2125]. For these patients, Markos and coworkers [10] recommend the following strategy: if predicted postoperative FEV1 is higher than 40%, pneumonectomy is possible; if predicted postoperative FEV1 is less than 30%, the degree of risk to perform a pneumonectomy appears to be prohibitive. Between these two values, these authors recommend using the diffusing capacity of carbon monoxide.

In our data, patients undergoing preoperative chemotherapy for lung cancer had lower postoperative complications rates than other patients. During treatment by chemotherapy, patients who stopped using tobacco were prepared for thoracic surgery. By analogy, two studies [6, 9] demonstrated that preoperative preparation with physiotherapy and medication reduces risks of postoperative complications.

Extended surgery is also a risk factor reported in the literature [11, 15]. Chest wall resections that cause deteriorating respiratory mechanics are responsible for postoperative pneumonia and atelectasis.

These risk group systems may provide for a possible improvement of selection of patients in risk group IV for lung resection. Patients in risk group III could benefit from a true preoperative program of pulmonary rehabilitation to decrease postoperative morbidity and mortality. For patients in the same risk group, aggressive postoperative care can be designed to reduce postoperative complications. The patients who belong to risk group I or II can have standard preoperative evaluation and postoperative management.

In conclusion, lobectomy and pneumonectomy remain a procedure with a high risk of postoperative complications. Using the expertise of the surgeon, anesthesiologist, pulmonologist, and respiratory therapist may minimize those risks. In a prospective study, based on these prognostic factors, a practical, easy-to-use risk grouping system of lung resection is proposed as a tool to aid the decision to perform lung resection.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 

  1. Ginsberg R.J., Hill L.D., Eagan R.T., et al. Modern thirty-day mortality for surgical resection in lung cancer. J Thorac Cardiovasc Surg 1983;86:654-658.[Abstract]
  2. Romano P.S., Roos L., Jollis J.G. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1085-1090.
  3. Greenacre M.J. Theory and applications of correspondence analysis. London: Academic Press, 1984.
  4. Dixon W.J. BMDP Statistical Software, Inc. Los Angeles: University of California Press, 1990:1047-1077 Vol 2..
  5. Breiman L., Freidman J.H., Olshen R.A., Stone C.J. Classification and regression trees. Belmont, CA: Wadsworth, 1984.
  6. Knott-Craig C., Howell E., Parsons B., et al. Improved results in the management of surgical candidates with lung cancer. Ann Thorac Surg 1997;63:1405-1410.[Abstract/Free Full Text]
  7. Ferguson M.K., Reeder B., Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg 1995;109:275-283.[Abstract/Free Full Text]
  8. Kearney D.J., Lee T.H., Reilly J.J., et al. Assessment of operative risk in patients undergoing lung resection. Chest 1994;105:753-759.[Abstract/Free Full Text]
  9. Dales R.E., Dionne G., Leech J.A., Lunau M., Schweitzer L. Preoperative prediction of pulmonary complications following thoracic surgery. Chest 1993;104:155-159.[Abstract/Free Full Text]
  10. Markos J., Mullan B., Hillman D., et al. Preoperative assessment as predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989;139:902-910.[Medline]
  11. Romano P.S., Mark D.H. Patients and hospital characteristics related to in hospital mortality after lung cancer resection. Chest 1992;101:1332-1337.[Abstract/Free Full Text]
  12. Whittle J., Steinberg E.P., Anderson G.F., Herbert R. Use of medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. Chest 1991;100:729-734.[Abstract/Free Full Text]
  13. Forster R., Toth S., Redmann K., et al. A prospective risk analysis of contemporary thoracic surgery. Eur J Cardio-thorac Surg 1996;10:641-648.[Abstract]
  14. Duque J.L., Ramos G., Castrodeza J. Early complications in surgical treatment of lung cancer—a prospective multicenter study. Ann Thorac Surg 1997;63:944-950.[Abstract/Free Full Text]
  15. Damhuis R.A.M., Schutte P.R. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur Respir J 1996;9:7-10.[Abstract]
  16. Gibetekin C., Martin P.G., Satur C.M., et al. Results of pneumonectomy for cancer in patients with limited ventilatory function. Eur J Cardiothorac Surg 1995;9:347-351.[Abstract]
  17. Kopec S.E., Irwin R.S., Umali-Torres C.B., et al. The postpneumonectomy state. Chest 1998;114:1158-1184.[Free Full Text]
  18. Harpole D.H., Liptay M.J., DeCamp M.M., Jr Prospective analysis of pneumonectomy risk factors for major morbidity and cardiac dysrythmias. Ann Thorac Surg 1996;61:977-982.[Abstract/Free Full Text]
  19. Tedder M., Anstadt M.P., Tedder S.D. Current morbidity, mortality and survival after bronchoplastic procedures for malignancy. Ann Thorac Surg 1992;54:387-391.[Abstract]
  20. Rea F., Loy M., Bortolotti L. Morbidity, mortality and survival after bronchoplastic procedures for lung cancer. Eur J Cardio-thorac Surg 1997;11:201-205.[Abstract]
  21. Pierce R.J., Copland J.M., Sharpe K., Barter C.E. Preoperative risk evaluation for lung cancer resection. Am J Crit Care Med 1994;150:947-955.[Abstract]
  22. Morice R.C., Peters E.J., Ryan M.B., Putnam J.B., Ali M.K., Roth J.A. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest 1992;101:356-361.[Abstract/Free Full Text]
  23. Walsh G.L., Morice R.C., Putnam J.B., Jr Resection of lung cancer is justified in high risk patients selected by exercise oxygen consumption. Ann Thorac Surg 1994;58:704-710.[Abstract]
  24. Epstein S.K., Faling L.J., Teli B.D., Celli B.R. Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest 1993;104:694-700.[Abstract/Free Full Text]
  25. Yano T., Yokoyama H., Fukuyama Y. The current status of postoperative complications, and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg 1997;11:445-449.[Abstract]
Accepted for publication May 2, 2000.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. D. Wright, H. A. Gaissert, J. D. Grab, S. M. O'Brien, E. D. Peterson, and M. S. Allen
Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model.
Ann. Thorac. Surg., June 1, 2008; 85(6): 1857 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Radu, F. Jaureguy, A. Seguin, C. Foulon, M. D. Destable, J. Azorin, and E. Martinod
Postoperative Pneumonia After Major Pulmonary Resections: An Unsolved Problem in Thoracic Surgery
Ann. Thorac. Surg., November 1, 2007; 84(5): 1669 - 1673.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
T.-E. Strand, H. Rostad, R. A M Damhuis, and J. Norstein
Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude
Thorax, November 1, 2007; 62(11): 991 - 997.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Weinstein, A. T. Bates, B. E. Spaltro, H. T. Thaler, and R. M. Steingart
Influence of Preoperative Exercise Capacity on Length of Stay After Thoracic Cancer Surgery
Ann. Thorac. Surg., July 1, 2007; 84(1): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Shaw
Genetics of postoperative complications following thoracic surgery.
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. Birim, A. P. Kappetein, M. Waleboer, J. P.A. Puvimanasinghe, M. J.C. Eijkemans, E. W. Steyerberg, M. I.M. Versteegh, and A. J.J.C. Bogers
Long-term survival after non-small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 491 - 498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O. Schussler, M. Alifano, H. Dermine, S. Strano, A. Casetta, S. Sepulveda, A. Chafik, S. Coignard, A. Rabbat, and J.-F. Regnard
Postoperative Pneumonia after Major Lung Resection
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Matsubara, S.-i. Takeda, and T. Mashimo
Risk Stratification for Lung Cancer Surgery: Impact of Induction Therapy and Extended Resection
Chest, November 1, 2005; 128(5): 3519 - 3525.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Perrot, B. Guibert, P. Mulsant, S. Blandin, I. Arnaud, P. Roy, L. Geriniere, and P.-J. Souquet
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
Ann. Thorac. Surg., August 1, 2005; 80(2): 423 - 427.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Magdeleinat, A. Seguin, M. Alifano, S. Boubia, and J.-F. Regnard
Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment
Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1099 - 1105.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Bernard, L. Benoit, C. Renaud, and J. P. Favre
Classification for predicting mediastinal lymph node metastases in patients with T1 or T2 lung cancer
Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 256 - 259.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. F. Lausberg, T. P. Graeter, D. Tscholl, O. Wendler, and H.-J. Schafers
Bronchovascular Versus Bronchial Sleeve Resection for Central Lung Tumors
Ann. Thorac. Surg., April 1, 2005; 79(4): 1147 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Brunelli, A. Fianchini, M. Al Refai, and M. Salati
A model for the internal evaluation of the quality of care after lung resection in the elderly
Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 884 - 889.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. Varela, N. Novoa, M.F. Jimenez, and G. Santos
Applicability of logistic regression (LR) risk modelling to decision making in lung cancer resection
Interactive CardioVascular and Thoracic Surgery, March 1, 2003; 2(1): 12 - 15.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. H. Hollaus, G. Wilfing, P. N. Wurnig, and N. S. Pridun
Risk factors for the development of postoperative complications after bronchial sleeve resection for malignancy: a univariate and multivariate analysis
Ann. Thorac. Surg., March 1, 2003; 75(3): 966 - 972.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. J. Ploeg, A. P. Kappetein, R. B. van Tongeren, P. V. Pahlplatz, G. W. Kastelein, and P. J. Breslau
Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung
Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 26 - 29.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Terzi, A. Lonardoni, G. Falezza, G. Furlan, P. Scanagatta, F. Pasini, and F. Calabro
Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases
Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Rocco
Predicting the Postoperative Outcome After Lung Surgery
Chest, December 1, 2001; 120(6): 1761 - 1761.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Myrdal, G. Gustafsson, M. Lambe, L.G. Horte, and E. Stahle
Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity
Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 694 - 699.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Novoa, G. Varela, and M.F. Jimenez
Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy
Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 700 - 704.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alain Bernard
Jean-Pierre Favre
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, A.
Right arrow Articles by Favre, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, A.
Right arrow Articles by Favre, J.-P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS